Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/2/2026
- Wall St set to open higher after June jobs report eases rate hike bets
- Oil falls to four-month low as US, Iran conclude talks in Doha
- Bond prices and stocks rally on softer payrolls, dollar falls
- Meta Platforms stock surges 8% on cloud business plans
- Humanoid robot component stocks surge on supply-chain optimism
Charles River Labs (CRL) PT Raised to $117 at RBC Capital
May 11, 2018 8:38 AM EDTRBC Capital raised its price target on Charles River Labs (NYSE: CRL) to $117.00 (from $116.00) while maintaining a Sector Perform rating.
... MoreCharles River Labs (CRL) PT Lowered to $111 at Evercore ISI
May 10, 2018 4:58 PM EDTEvercore ISI lowered its price target on Charles River Labs (NYSE: CRL) to $111.00 (from $116.00) while maintaining a In Line rating.
... MoreCharles River Laboratories (CRL) Tops Q1 EPS by 12c, Raises FY EPS Guidance
May 10, 2018 7:07 AM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $1.38, $0.12 better than the analyst estimate of $1.26. Revenue for the quarter came in at $494.4 million versus the consensus estimate of $480.75 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.77-$5.92, versus the consensus of... More
